Author Hohloch, Karin

1 to 20 of 39 Items

1999 | Journal Article
Rapid mucosal CD4+ T-cell depletion and enteropathy in simian immunodeficiency virus–infected rhesus macaques
Kewenig, S.; Schneider, T.; Hohloch, K.; Lampe–Dreyer, K.; Ullrich, R.; Stolte, N. & Stahl–Hennig, C. et al. (1999)
Gastroenterology, 116(5) pp. 1115-1123. DOI: https://doi.org/10.1016/S0016-5085(99)70014-4
Details DOI

2003 | Journal Article
Aplastic anemia - Diagnosis
Hohloch, K.; Truemper, L. H. & Schroers, R. (2003)
DMW - Deutsche Medizinische Wochenschrift, 128(36) pp. 1838-1840.
Details PMID PMC WoS

2003 | Journal Article
Aplastic anemia - Treatment
Schroers, R.; Hohloch, K. & Truemper, L. H. (2003)
DMW - Deutsche Medizinische Wochenschrift, 128(36) pp. 1841-1844.
Details PMID PMC WoS

2003 | Journal Article |
Aplastic anemia - Case Report
Schroers, R.; Hohloch, K. & Truemper, L. H. (2003)
Deutsche medizinische Wochenschrift, 128(36) pp. 1837-1837. DOI: https://doi.org/10.1055/s-2003-41962
Details DOI PMID PMC WoS

2004 | Conference Paper
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
Kollmannsberger, C.; Beyer, J.; Liersch, R.; Schoeffski, P.; Metzner, B.; Rick, O. & Hartmann, J. T. et al. (2004)
Journal of Clinical Oncology, 22(1) pp. 108-114. 39th Annual Meeting of the American-Society-of-Clinical-Oncology, CHICAGO, ILLINOIS.
Alexandria: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/JCO.2004.06.068
Details DOI PMID PMC WoS

2005 | Conference Abstract
Tandem high dose chemotherapy and myeloablative radioimmunotherapy with 131-I-anti-CD20 rituximab in relapsed and refractory B-cell lymphoma: Interim results of a phase II study of the German RIT study group
Hohloch, K.; Wulf, G.; Glass, B.; Jung, W.; Stitz, E.; Meller, J. & Sahlmann, C.-O. et al. (2005)
Annals of Oncology, 16 9th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS

2005 | Conference Abstract
Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics of melphalan
Kuhne, A.; Kaiser, R.; Schirmer, M. A.; Muhlke, S.; Niere, W.; Wasser, K. & Overbeck, T. R. et al. (2005)
European Journal of Clinical Pharmacology, 61(9) 7th Annual Congress of Clinical Pharmacology, Dresen, GERMANY.
New york: Springer.
Details WoS

2005 | Conference Abstract
Pharmacokinetics of melphalan and genotypes of glutathione S-transferases GSTM1 and GSTT1 and correlation to adverse effects.
Kuhne, A.; Muhlke, S.; Heider, U.; Overbeck, T. R.; Hohloch, K.; Meineke, I. & Truemper, L. H. et al. (2005)
Journal of Clinical Oncology, 23(16) 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando, FL.
Alexandria: Amer Soc Clinical Oncology.
Details WoS

2006 | Conference Abstract
CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003-1): Feasibility and toxicity of a phase II trial of the German High Grade Non-Hodgkin's Lymphoma Group DSHNHL.
Truemper, L. H.; Hohloch, K.; Kloess, M.; Duehrsen, U.; Eimermacher, H.; Haas, A. & Aldaoud, A. et al. (2006)
Journal of Clinical Oncology, 24(18) 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, Atlanta, GA.
Alexandria: Amer Soc Clinical Oncology.
Details WoS

2007 | Journal Article
Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan
Kühne, A.; Kaiser, R.; Schirmer, M.; Heider, U.; Muhlke, S.; Niere, W. & Overbeck, T. et al. (2007)
Pharmacogenetics and Genomics, 17(7) pp. 505-517. DOI: https://doi.org/10.1097/FPC.0b013e3280ea77cd
Details DOI PMID PMC WoS

2008 | Conference Abstract
Significant dose escalation of Idarubicin in the treatment of low risk aggressive non-Hodgkin's lymphoma leads to increased hematotoxicity and decreased efficacy: Nine year follow up of a phase-I/II trial of the DSHNHL
Hohloch, K.; Zwick, C.; Zeipert, M.; Kaiser, U.; Engert, A.; Reiser, M. & Hoeffkes, H.-G. et al. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS

2008 | Conference Abstract
Tandem HD-chemotherapy and myeloablative radioimmunotherapy with 131I-anti-CD20 rituximab in relapsed and refractory B-cell lymphoma: Final results of a phase II study of the German Rait Study Group
Hohloch, K.; Lakhani, V. J.; Sahlmann, C.-O.; Wulf, G.; Jung, W.; Glass, B. & Meller, J. et al. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS

2008 | Conference Abstract
The RIT Network provides real life clinical data on radioimmunotherapy for lymphoma: An international registry for radioimmunotherapy-treated patients
Hohloch, K.; Lorsbach, M.; Zinzani, P. L.; Chairman, N. & Truemper, L. H. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS

2008 | Journal Article |
Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects
Kuehne, A.; Sezer, O.; Heider, U.; Meineke, I.; Muhlke, S.; Niere, W. & Overbeck, T. R. et al. (2008)
Clinical Pharmacology & Therapeutics, 83(5) pp. 749-757. DOI: https://doi.org/10.1038/sj.clpt.6100336
Details DOI PMID PMC WoS

2009 | Journal Article
A Case of Bilateral Optic Disc Edema
Pfriem, M.; Overbeck, T. R.; Hohloch, K.; Tondrow, M. & Hoerauf, H. (2009)
Klinische Monatsblätter für Augenheilkunde, 226(2) pp. 130-131. DOI: https://doi.org/10.1055/s-2008-1027962
Details DOI PMID PMC WoS

2009 | Conference Paper
Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group
Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buehler, A.; Schlenk, R. F.; Groner, S. & Busch, R. et al. (2009)
Journal of Clinical Oncology, 27(24) pp. 3994-4001. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA.
Alexandria: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/JCO.2008.21.1128
Details DOI PMID PMC WoS

2009 | Journal Article
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
Buske, C.; Hoster, E.; Dreyling, M.; Eimermacher, H.; Wandt, H.; Metzner, B. & Fuchs, R. et al. (2009)
Leukemia, 23(1) pp. 153-161. DOI: https://doi.org/10.1038/leu.2008.261
Details DOI PMID PMC WoS

2009 | Journal Article
Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma
Gregory, S. A.; Hohloch, K.; Gisselbrecht, C.; Tobinai, K. & Dreyling, M. H. (2009)
The Oncologist, 14 pp. 4-16. DOI: https://doi.org/10.1634/theoncologist.2009-S2-4
Details DOI PMID PMC WoS

2010 | Conference Abstract
Radioimmunotherapy for consolidation and relapse therapy for aggressive B-cell non-Hodgkin lymphoma: Retrospective analysis of the International RIT-Network.
Hohloch, K.; Windermuth-Kiesselbach, C.; Lorsbach, M.; Zinzani, P. L. & Truemper, L. H. (2010)
Journal of Clinical Oncology, 28(15)
Alexandria: Amer Soc Clinical Oncology.
Details WoS

2011 | Conference Abstract
RADIOIMMUNOTHERAPY FOR CONSOLIDATION AND RELAPSE TREATMENT OF AGGRESSIVE B-CELL NON HODGKINS LYMPHOMA: AN UPDATED ANALYSIS OF THE INTERNATIONAL RIT-NETWORK
Hohloch, K.; Lankeit, H. K.; Zinzani, P. L.; Lorsbach, M.; Windemuth-Kiesselbach, C. & Truemper, L. H. (2011)
Annals of Oncology, 22 11th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100